GIST
Showing 1 - 25 of 404
Gastrointestinal Stromal Tumors Trial in Houston (Regorafenib)
Not yet recruiting
- Gastrointestinal Stromal Tumors
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2023
Gastrointestinal Stromal Tumor of Rectum Trial in Fuzhou (Imatinib Mesylate, Local resection)
Not yet recruiting
- Gastrointestinal Stromal Tumor of Rectum
- Imatinib Mesylate
- Local resection
-
Fuzhou, Fujian, ChinaWeizhong Jiang
Jul 23, 2023
Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)
Active, not recruiting
- Gastrointestinal Stromal Tumor (GIST)
- MEK162
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 28, 2022
Gastrointestinal Stromal Tumors Trial in Miami (Sunitinib, Regorafenib)
Recruiting
- Gastrointestinal Stromal Tumors
-
Miami, FloridaUniversity of Miami
Jan 3, 2023
Imatinib With Hepatic Resection or Other Local Treatment for
Completed
- GIST, Malignant
- Liver Metastases
- imatinib (IM)
- +3 more
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital of Sun Yat-sen University
Sep 12, 2023
Gastrointestinal Stromal Tumors Trial in Seoul (Paclitaxel)
Recruiting
- Gastrointestinal Stromal Tumors
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
Clinical Evaluation of Genetron D842V PCR Kit in GIST Patients
Completed
- GIST
- Gastrointestinal Stromal Tumors
-
Beijing, China
- +2 more
Jun 1, 2022
Communication Training Intervention for Large B-Cell Lymphoma
Recruiting
- Lymphoma, B-Cell
- +5 more
- Hematolo-GIST Training
- Participants Appointment
-
New York, New York
- +2 more
Jul 3, 2023
GIST, Malignant, CBT Trial in Pittsburgh (MAAT)
Recruiting
- GIST, Malignant
- CBT
- MAAT
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Apr 15, 2022
Ripretinib in Chinese Advanced GIST: a Real World Study
Active, not recruiting
- Gastrointestinal Stromal Tumors
- Ripretinib Oral Tablet
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 15, 2023
Avapritinib in Chinese Gastrointestinal Stromal Tumor in Real
Recruiting
- Gastrointestinal Stromal Tumors
- Avapritinib
- Tyrosine kinase inhibitors other than avapritinib ( imatinib, sunitinib, et al )
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 14, 2022
Gastrointestinal Stromal Tumors, GIST Trial (Avapritinib, midazolam)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- GIST
- (no location specified)
Jul 20, 2022
GIST Trial in Xi'an (Imatinib)
Recruiting
- GIST
-
Xi'an, Shaanxi, ChinaXijing Hospital of Air Force Military Medical University
Jun 8, 2023
Gastrointestinal Stromal Tumors Trial in Tokyo (Pimitespib, Imatinib, Sunitinib)
Recruiting
- Gastrointestinal Stromal Tumors
- Pimitespib
- +2 more
-
Tokyo, JapanA site selected by Taiho Pharmaceutical Co., Ltd.
Aug 4, 2022
Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Recruiting
- Gastrointestinal Stromal Tumors
- Minimal Residual Disease
- liquid biopsy
-
Beijing, Beijing, ChinaPeking University People'S Hospital
Sep 18, 2022
Gastric GIST Trial in Hong Kong (Endoscopic Full Thickness Resection)
Recruiting
- Gastric GIST
- Endoscopic Full Thickness Resection
-
Hong Kong, Outside Of US & Canada, ChinaDepartment of Surgery, Faculty of Medicine, The Chinese Universi
Feb 21, 2022
Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases Trial in Boston (IDRX-42)
Recruiting
- Gastrointestinal Stromal Tumor (GIST)
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 16, 2022
Liver Diseases, Liver Cancer, Liver Metastases Trial in Murcia (Liver Transplantation)
Not yet recruiting
- Liver Diseases
- +27 more
- Liver Transplantation
-
Murcia, SpainFelipe Alconchel
Feb 24, 2022
Unresectable Gastrointestinal Stromal Tumor (GIST), Locally Advanced Gastrointestinal Stromal Tumor (GIST), Metastatic
Recruiting
- Unresectable Gastrointestinal Stromal Tumor (GIST)
- +2 more
- Atezolizumab 1200 mg
- Imatinib 400 MG
-
Lyon, Rhône, France
- +4 more
Apr 28, 2022
Gastrointestinal Stromal Tumor Trial (Everolimus)
Temporarily not available
- Gastrointestinal Stromal Tumor
- (no location specified)
May 5, 2022
Gastrointestinal Stromal Tumors Trial in Seoul (Rivoceranib Mesylate, Paclitaxel)
Not yet recruiting
- Gastrointestinal Stromal Tumors
- Rivoceranib Mesylate, Paclitaxel
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Jun 7, 2023
Gastrointestinal Stromal Tumor Trial in Oslo (Discontinuation of imatinib)
Suspended
- Gastrointestinal Stromal Tumor
- Discontinuation of imatinib
-
Oslo, NorwayOslo University Hospital
Feb 7, 2022
Clinical Research of Drug Holiday Based on MRD Detection in GIST
Recruiting
- Gastrointestinal Stromal Tumors
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 11, 2023